229 related articles for article (PubMed ID: 30935403)
1. Mild thermotherapy and hyperbaric oxygen enhance sensitivity of TMZ/PSi nanoparticles via decreasing the stemness in glioma.
Zeng X; Wang Q; Tan X; Jia L; Li Y; Hu M; Zhang Z; Bai X; Zhu Y; Yang X
J Nanobiotechnology; 2019 Apr; 17(1):47. PubMed ID: 30935403
[TBL] [Abstract][Full Text] [Related]
2. Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2/M phase arrest.
Xie Y; Zeng X; Wu X; Hu J; Zhu Y; Yang X
Nanomedicine (Lond); 2018 Apr; 13(8):887-898. PubMed ID: 29473458
[TBL] [Abstract][Full Text] [Related]
3. The synergistic therapeutic effect of temozolomide and hyperbaric oxygen on glioma U251 cell lines is accompanied by alterations in vascular endothelial growth factor and multidrug resistance-associated protein-1 levels.
Lu XY; Cao K; Li QY; Yuan ZC; Lu PS
J Int Med Res; 2012; 40(3):995-1004. PubMed ID: 22906272
[TBL] [Abstract][Full Text] [Related]
4. Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.
Dagıstan Y; Karaca I; Bozkurt ER; Ozar E; Yagmurlu K; Toklu A; Bilir A
Acta Cir Bras; 2012 Jun; 27(6):383-7. PubMed ID: 22666755
[TBL] [Abstract][Full Text] [Related]
5. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
6. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
[TBL] [Abstract][Full Text] [Related]
7. Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.
Li XQ; Ouyang ZG; Zhang SH; Liu H; Shang Y; Li Y; Zhen YS
J Neurooncol; 2014 Aug; 119(1):91-100. PubMed ID: 24842385
[TBL] [Abstract][Full Text] [Related]
8. Effects of Far-infrared Ray on Temozolomide-treated Glioma in Rats.
Chen JC; Hwang JH
In Vivo; 2019; 33(4):1203-1208. PubMed ID: 31280210
[TBL] [Abstract][Full Text] [Related]
9. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).
Choi J; Lee JH; Koh I; Shim JK; Park J; Jeon JY; Yun M; Kim SH; Yook JI; Kim EH; Chang JH; Kim SH; Huh YM; Lee SJ; Pollak M; Kim P; Kang SG; Cheong JH
Oncotarget; 2016 Oct; 7(40):65643-65659. PubMed ID: 27582539
[TBL] [Abstract][Full Text] [Related]
11. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
12. Acquisition of temozolomide resistance by the rat C6 glioma cell line increases cell migration and side population phenotype.
Xu Y; Yang X; Mei S; Sun Y; Li J
Oncol Rep; 2019 Dec; 42(6):2355-2362. PubMed ID: 31578583
[TBL] [Abstract][Full Text] [Related]
13. DMC is not better than TMZ on intracranial anti-glioma effects.
Shi L; Sun G
J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236
[TBL] [Abstract][Full Text] [Related]
14. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells.
Wang Y; Gao S; Wang W; Liang J
Mol Med Rep; 2016 Dec; 14(6):5732-5738. PubMed ID: 27878252
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma.
Bikhezar F; de Kruijff RM; van der Meer AJGM; Torrelo Villa G; van der Pol SMA; Becerril Aragon G; Gasol Garcia A; Narayan RS; de Vries HE; Slotman BJ; Denkova AG; Sminia P
J Neurooncol; 2020 Jan; 146(2):239-246. PubMed ID: 31875307
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells.
Zhang X; Ni Q; Wang Y; Fan H; Li Y
Biol Pharm Bull; 2018 Aug; 41(8):1194-1202. PubMed ID: 29848900
[TBL] [Abstract][Full Text] [Related]
18. Iguratimod encapsulated PLGA-NPs improves therapeutic outcome in glioma, glioma stem-like cells and temozolomide resistant glioma cells.
Younis M; Faming W; Hongyan Z; Mengmeng T; Hang S; Liudi Y
Nanomedicine; 2019 Nov; 22():102101. PubMed ID: 31654739
[TBL] [Abstract][Full Text] [Related]
19. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
[TBL] [Abstract][Full Text] [Related]
20. Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy.
Hwang TW; Kim DH; Kim DB; Jang TW; Kim GH; Moon M; Yoon KA; Choi DE; Park JH; Kim JJ
Int J Mol Med; 2019 Mar; 43(3):1478-1486. PubMed ID: 30664150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]